Obesity-driven inflammation enables triple-negative breast cancer progression through immunosuppression [scRNA-Seq]
control and obese,  C57BL6J mice with or without sulindac treatment were injected with E0771 cells and tumor growth was monitored Overall design: whole tumors were dissociated by cold protease, and subjected to 10x genomics scRNAseq analysis